Note: Live price is not available for this stock. Showing closing price. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
AARTIPHARM Stock Analysis
Views
Red Flags
Positive
Strong price momentum
High and stable operating margin
Low Debt to Equity, not much change from last year
Negative
Expensive and at same valuation levels as industry median P/E
Low revenue growth and lower than median growth of industry
Low dividend yield
Neutral
Moderate and stable ROE
Low EPS growth but above median growth of industry
Company's earnings are of moderate quality
No red flags found!
No significant red flags found in the stock.
Snapshot
See detailed analysis
AARTIPHARM Shareholding Pattern
An overview of who owns the company. Click on chart icon to view historical movement.
AARTIPHARM Bulk, Block & Insider Trades
AARTIPHARM Dividends, Splits & Bonus
Dividend Events
Capital Change Events
No capital change events found
Company Profile
Aarti Pharmalabs Limited is engaged in the manufacturing of active pharmaceutical ingredients (APIs), advanced intermediates, and xanthine derivatives, based in India. The Company also offers comprehensive contract development and manufacturing organization (CDMO) and CMO services for drug substance... Read More
Key personnel
Shri. Rashesh Chandrakan GogriD
Chairman of the Board
Mr. Jeevan Bhargav Mondkar
Company Secretary and Compliance Officer
Smt. Hetal Gogri GalaD
Director
Mr. Chetan Bipin GandhiD
Director
Mr. Rajendra Vallabhaji GogriD
Director
Shri. Narendra Jagannath SalviD
Director
Smt. Nehal GarewalD
Non-Executive Non-Independent Director
Shri. Pradeep H ThakurD
Non-Executive Independent Director
View all
Incorporated on
Last Annual
Last Interim
No. of Employees
IPO date
Free Float
Website
Phone no.
Address
Frequently asked questions
What is the current share price of Aarti Pharmalabs Ltd.?
The current share price of Aarti Pharmalabs Ltd. is ₹ 761.52 as of 09 Jan 2026.
What is the PE ratio of Aarti Pharmalabs Ltd.?
The Price-to-Earnings (PE) ratio of Aarti Pharmalabs Ltd. is 28.79 as of the latest financial data.
What is the ROE and ROCE of Aarti Pharmalabs Ltd.?
Aarti Pharmalabs Ltd. has a Return on Equity (ROE) of 12.29% and a Return on Capital Employed (ROCE) of 15.05% as per the latest financial reports.
What is the market cap of Aarti Pharmalabs Ltd.?
The market capitalization of Aarti Pharmalabs Ltd. stands at ₹ 6,902.49 Cr.
What is the dividend yield of Aarti Pharmalabs Ltd.?
The dividend yield of Aarti Pharmalabs Ltd. is 0.66% based on the current market price.
What is the RSI of Aarti Pharmalabs Ltd.?
The Relative Strength Index (RSI) of Aarti Pharmalabs Ltd. is 54.82.
What is the FII and DII holding in Aarti Pharmalabs Ltd.?
Foreign Institutional Investors (FII) hold 8.02% and Domestic Institutional Investors (DII) hold 6.09% of Aarti Pharmalabs Ltd. shares.
What sector does Aarti Pharmalabs Ltd. belong to?
Aarti Pharmalabs Ltd. operates in the Healthcare sector.
What is the beta of Aarti Pharmalabs Ltd. stock?
The beta of Aarti Pharmalabs Ltd. stock is 1.11, indicating its volatility relative to the broader market.
